Prevention of Clostridium difficilespore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam

Adaptive Strategies and Pathogenesis of Clostridium difficile fromIn VivoTranscriptomics

(2013) Claire Janoir et al.   INFECTION AND IMMUNITY

Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile

(2013) M. J. Aldape et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Vancomycin Treatment's Association with Delayed Intestinal Tissue Injury, Clostridial Overgrowth, and Recurrence of Clostridium difficile Infection in Mice

(2012) C. A. Warren et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Fidaxomicin Inhibits Spore Production in Clostridium difficile

(2012) Farah Babakhani et al.   CLINICAL INFECTIOUS DISEASES

Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection

(2012) D. Bossé et al.   INFECTION

Fidaxomicin inhibits toxin production in Clostridium difficile

(2012) F. Babakhani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile

(2012) T. Thapa et al.   JOURNAL OF BACTERIOLOGY

Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0A

(2012) Lisa F. Dawson et al.   PLoS One

Tigecycline for the Treatment of Severe Clostridium difficile Infection

(2011) Kelly C Larson et al.   ANNALS OF PHARMACOTHERAPY

Relapse Versus Reinfection: Surveillance of Clostridium difficile Infection

(2011) M. Kamboj et al.   CLINICAL INFECTIOUS DISEASES

Mouse Relapse Model of Clostridium difficile Infection

(2011) Xingmin Sun et al.   INFECTION AND IMMUNITY

Activity of RBx 11760, a novel biaryl oxazolidinone, against Clostridium difficile

(2011) T. Mathur et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Lack of Association between Clinical Outcome of Clostridium difficile Infections, Strain Type, and Virulence-Associated Phenotypes

(2011) S. Sirard et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Treatment of refractory and recurrent Clostridium difficile infection

(2011) Christina M. Surawicz et al.   Nature Reviews Gastroenterology & Hepatology

Reconsidering the Sporulation Characteristics of Hypervirulent Clostridium difficile BI/NAP1/027

(2011) David A. Burns et al.   PLoS One

Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole

(2010) Ching-Lan Lu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Effects of Subinhibitory Concentrations of Antibiotics on Colonization Factor Expression by Moxifloxacin-Susceptible and Moxifloxacin-Resistant Clostridium difficile Strains

(2009) C. Deneve et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Typing Clostridium difficile strains based on tandem repeat sequences

(2009) N HENNING ZaiSS et al.   BMC MICROBIOLOGY

Intravenous Tigecycline as Adjunctive or Alternative Therapy for Severe RefractoryClostridium difficileInfection

(2009) Bjorn L. Herpers et al.   CLINICAL INFECTIOUS DISEASES

Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised Hosts

(2009) T. D. Lawley et al.   INFECTION AND IMMUNITY

Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model

(2009) U. A. Ochsner et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes

(2009) Stuart Johnson   JOURNAL OF INFECTION

Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model

(2008) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Decreased Diversity of the Fecal Microbiome in RecurrentClostridium difficile–Associated Diarrhea

(2008) Ju Young Chang et al.   JOURNAL OF INFECTIOUS DISEASES

Microarray analysis of the transcriptional responses of Clostridium difficile to environmental and antibiotic stress

(2008) J. E. Emerson et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile

(2008) M. Gerber et al.   JOURNAL OF MEDICAL MICROBIOLOGY